More News

15 Feb 2007 Halozyme and Baxter Expand Global HYLENEX Collaboration
15 Feb 2007 Halozyme Therapeutics and Baxter Present Promising Results for the Use of HYLENEX from the Infuse-Morphine Study
14 Feb 2007 InSite Vision Announces Positive Top-Line Safety Results from Phase 1 AzaSite Plus Clinical Study
14 Feb 2007 Organon and Pharmacopeia Enter Into Discovery, Development and Commercialization Alliance
14 Feb 2007 Elixir Pharmaceuticals and Siena Biotech S.p.A. Enter Agreement to Evaluate SIRT1 Inhibitors in Huntington's Disease
14 Feb 2007 Osiris Announces Top-Line Interim Results for Stem Cell Trial for Knee Repair
13 Feb 2007 AVANT Immunotherapeutics and Select Vaccines Announce Partnership to Develop Improved Viral Vaccines
13 Feb 2007 Adeza to Be Acquired by Cytyc for $24 Per Share
13 Feb 2007 Medivir Outlicenses The Antiviral Compound MIV-160 To Guangdong Lantai Viewland Pharmaceutical CO. LTD
10 Feb 2007 Q-Med has entered into a development and commercialisation agreement regarding botulinum toxin products
10 Feb 2007 Q-Med has entered into a development and commercialisation agreement regarding botulinum toxin products
09 Feb 2007 GlaxoSmithKline and XenoPort announce agreement on late-stage compound for RLS and neuropathic pain
09 Feb 2007 Corautus Genetics and VIA Pharmaceuticals Announce Merger Agreement
09 Feb 2007 Ranbaxy Gains Final US FDA Approval For Sertraline Hydrochloride Tablets
09 Feb 2007 Mylan Announces Final FDA Approval for Sotalol Hydrochloride Tablets, USP (AF)
09 Feb 2007 In-licensing of MuGard(TM) from Access Pharmaceuticals
09 Feb 2007 Advanced BioHealing Enrolls First Patient in Celaderm Pilot Venous Leg Ulcer Clinical Trial
09 Feb 2007 Advanced BioHealing Enrolls First Patient in Celaderm Pilot Venous Leg Ulcer Clinical Trial
09 Feb 2007 GlaxoSmithKline and Fabre-Kramer Pharmaceuticals enter global agreement for new treatment of major depressive disorder
09 Feb 2007 SRI International and Telik Announce Exclusive License for SRI to Develop Autoimmune and Inflammatory Disease Drug Candidate
09 Feb 2007 BioSyntech announces start of patient recruitment into BST-DermOn(TM) pivotal clinical trial
09 Feb 2007 BioSyntech announces start of patient recruitment into BST-DermOn(TM) pivotal clinical trial
08 Feb 2007 Ranbaxy Announces Global Entry Into Biosimilars With Zenotech
08 Feb 2007 Lupin Pharmaceuticals, Inc. Receives US FDA Approval For Sertraline
07 Feb 2007 ImClone Systems Opts-out of Development Agreement with UCB to Focus Resources on Proprietary, Anti-VEGFr-2 Antibody IMC-1121B

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top